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Fibroblast growth factor 23 (FGF23) is a circulating fac-
tor that plays a central role in the renal reabsorption of
Pi and metabolism of vitamin D. It is mainly produced by
osteocytes in bone and exerts its effects on distant organs
such as the kidney and parathyroid in an endocrine fash-
ion. FGF23 increases renal Pi excretion by reducing the
expression of type 2a and 2c sodium/phosphate (Na+/Pi)
co-transporters in the proximal tubules. In addition, it
decreases the renal production of 1,25-dihydroxyvitamin
D [1,25(OH)2D] by suppressing the expression of
25-hydroxyvitamin D-1a-hydroxylase and increasing that
of 25-hydroxyvitamin D-24-hydroxylase. FGF23 requires
a-Klotho as well as FGF receptor to exert its effects.
FGF23 consists of 251 amino acids. Loss of function
mutations in FGF23 cause familial tumoral calcinosis,
which is characterized by hyperphosphatemia and
increased levels of 1,25(OH)2D. Autosomal dominant
hereditary hypophosphatemic rickets (ADHR) is caused
by mutations in the cleavage RXXR motif, which prevent
inactivation of FGF23. Excess of FGF23 action results in
renal phosphate wasting and an inappropriately low level
of serum 1,25(OH)2D. Recent studies have implicated the
iron-deficiency in the late manifestation of ADHR.
Tumor-induced osteomalacia is an acquired paraneoplas-
tic syndrome of renal phosphate wasting caused by over-
production of FGF23 by tumors.
Among hereditary hypophosphatemic rickets/osteomala-
cia, X-linked hypophosphatemic rickets (XLH) is the most
common form and is caused by deletion or inactivating
mutations of the phosphate-regulating gene homologous
to endopeptidase on X chromosome (PHEX). Autosomal
recessive hypophosphatemic rickets type I and type II are
caused by inactivating mutations of dentin matrix protein
1 (DMP1) and ectonucreotide pyrophosphatase/phospho-
diesterase 1 (ENPP1), respectively. In these conditions,
serum FGF23 levels are increased, which is responsible for
the renal phosphate wasting and impaired vitamin D
metabolism. FAM20C is a secreted kinase that phosphory-
lates extracellular proteins including DMP1. Recently,
inactivating mutations in FAM20C have been reported in
patients with increased levels of FGF23 and hypophospha-
temia. PHEX, DMP1 and FAM20C as well as FGF23 are
highly expressed in osteocytes, indicating the critical role
of osteocytes in mineral metabolism. Hypophosphatemic
rickets/osteomalacia caused by the increased bioactivity of
FGF23 are classified into FGF23-mediated hypophosphate-
mic rickets/osteomalacia. Measurement of serum levels of
FGF23 is useful for diagnosis of these conditions. Neutrali-
zation of FGF23 will be a potential treatment for XLH and
other FGF23-mediated hypophosphatemic rickets/
osteomalacia.
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